N-Able Inc expected to post earnings of 10 cents a share - Earnings Preview
N-Able Inc expected to post earnings of 10 cents a share - Earnings Preview
N-Able Inc NABL.N, NABL.K is expected to show a rise in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2026
The Wilmington Delaware-based company is expected to report a 5.1% increase in revenue to $137.954 million from $131.25 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
LSEG's mean analyst estimate for N-Able Inc is for earnings of 10 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for N-Able Inc is $6.00, about 28.2% above its last closing price of $4.68
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 0.09 | 0.09 | 0.09 | Met | 1.9 |
Dec. 31 2026 | 0.10 | 0.10 | 0.06 | Missed | -40 |
Sep. 30 2025 | 0.09 | 0.09 | 0.13 | Beat | 44.4 |
Jun. 30 2025 | 0.09 | 0.09 | 0.11 | Beat | 24.2 |
Mar. 31 2025 | 0.07 | 0.07 | 0.08 | Beat | 19.7 |
Dec. 31 2024 | 0.08 | 0.08 | 0.10 | Beat | 27.7 |
Sep. 30 2024 | 0.10 | 0.10 | 0.13 | Beat | 33.5 |
Jun. 30 2024 | 0.11 | 0.10 | 0.14 | Beat | 34.6 |
This summary was machine generated August 3 at 13:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on N-Able
See all newsBrief: As Ai Accelerates Cyberattacks, N-Able And Sentinelone Expand Their Strategic Partnership To Advance Resilience
Brief: N-Able Announces $50 Million Increase To Share Repurchase Program
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
N-Able Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: N-Able On July 20, Announces To Reduce Global Workforce By About 6% - SEC Filing